25 XP   0   0   10

Hangzhou Tigermed Consulting Co Ltd
Buy, Hold or Sell?

Let's analyse Hangzhou Tigermed Consulting Co Ltd together

PenkeI guess you are interested in Hangzhou Tigermed Consulting Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Hangzhou Tigermed Consulting Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Hangzhou Tigermed Consulting Co Ltd

I send you an email if I find something interesting about Hangzhou Tigermed Consulting Co Ltd.

Quick analysis of Hangzhou Tigermed Consulting Co Ltd (30 sec.)










What can you expect buying and holding a share of Hangzhou Tigermed Consulting Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.09
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
HK$30.45
Expected worth in 1 year
HK$33.38
How sure are you?
88.2%

+ What do you gain per year?

Total Gains per Share
HK$3.62
Return On Investment
12.5%

For what price can you sell your share?

Current Price per Share
HK$29.05
Expected price per share
HK$22.10 - HK$36.75
How sure are you?
50%

1. Valuation of Hangzhou Tigermed Consulting Co Ltd (5 min.)




Live pricePrice per Share (EOD)

HK$29.05

Intrinsic Value Per Share

HK$11.21 - HK$12.98

Total Value Per Share

HK$41.66 - HK$43.43

2. Growth of Hangzhou Tigermed Consulting Co Ltd (5 min.)




Is Hangzhou Tigermed Consulting Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$3.3b$2.9b$92.2m3.0%

How much money is Hangzhou Tigermed Consulting Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$113.1m$93.2m$19.8m17.6%
Net Profit Margin29.5%37.3%--

How much money comes from the company's main activities?

3. Financial Health of Hangzhou Tigermed Consulting Co Ltd (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#16 / 148

Most Revenue
#36 / 148

Most Profit
#20 / 148

What can you expect buying and holding a share of Hangzhou Tigermed Consulting Co Ltd? (5 min.)

Welcome investor! Hangzhou Tigermed Consulting Co Ltd's management wants to use your money to grow the business. In return you get a share of Hangzhou Tigermed Consulting Co Ltd.

What can you expect buying and holding a share of Hangzhou Tigermed Consulting Co Ltd?

First you should know what it really means to hold a share of Hangzhou Tigermed Consulting Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Hangzhou Tigermed Consulting Co Ltd is HK$29.05. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Hangzhou Tigermed Consulting Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Hangzhou Tigermed Consulting Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$30.45. Based on the TTM, the Book Value Change Per Share is HK$0.73 per quarter. Based on the YOY, the Book Value Change Per Share is HK$0.80 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.17 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Hangzhou Tigermed Consulting Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps0.080.3%0.100.3%0.110.4%0.090.3%0.090.3%
Usd Book Value Change Per Share0.622.1%0.090.3%0.100.4%0.230.8%0.230.8%
Usd Dividend Per Share0.080.3%0.020.1%0.020.1%0.020.1%0.020.1%
Usd Total Gains Per Share0.702.4%0.120.4%0.120.4%0.250.8%0.250.8%
Usd Price Per Share5.25-7.98-11.14-10.45-10.45-
Price to Earnings Ratio16.86-22.80-28.39-31.51-31.51-
Price-to-Total Gains Ratio7.50--4.67-95.03-112.25-112.25-
Price to Book Ratio1.35-2.34-3.31-3.35-3.35-
Price-to-Total Gains Ratio7.50--4.67-95.03-112.25-112.25-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.71259
Number of shares269
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.02
Usd Book Value Change Per Share0.090.23
Usd Total Gains Per Share0.120.25
Gains per Quarter (269 shares)31.1066.07
Gains per Year (269 shares)124.40264.28
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
12410111418246254
24820123836493518
37230236254739782
495402486729851046
51195036109012321310
614360373410814781574
716770485812617241838
819180498214419712102
9215905110616222172366
102391005123018024632630

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%17.00.00.0100.0%17.00.00.0100.0%17.00.00.0100.0%
Book Value Change Per Share2.02.00.050.0%10.02.00.083.3%15.02.00.088.2%15.02.00.088.2%15.02.00.088.2%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%17.00.00.0100.0%17.00.00.0100.0%17.00.00.0100.0%
Total Gains per Share2.02.00.050.0%10.02.00.083.3%15.02.00.088.2%15.02.00.088.2%15.02.00.088.2%

Fundamentals of Hangzhou Tigermed Consulting Co Ltd

About Hangzhou Tigermed Consulting Co Ltd

Hangzhou Tigermed Consulting Co., Ltd provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers preclinical development services, including medicinal chemistry, compound screening, DMPK, safety and toxicology, bioanalytical, and formulation research and development services; and clinical development services, such as medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, clinical development strategy, site management, subject recruitment, medical device/ in vitro diagnostics, multi-region clinical trial, and vaccine clinical trial services. It also provides product market research, product marketing strategy, product finalization, product verification, registration strategy planning, marketing application, post-marketing supports, and product upgrade services. In addition, the company offers medical imaging, pharmacovigilance, medical translation, quality assurance, GMP consulting, central laboratories, functional services, EDC system, and call center services; and post-marketing clinical research solutions, such as site identification and selection, central monitoring, project team management, vendor management, and project management services. Hangzhou Tigermed Consulting Co., Ltd was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.

Fundamental data was last updated by Penke on 2024-03-26 05:34:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Hangzhou Tigermed Consulting Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Hangzhou Tigermed Consulting Co Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Hangzhou Tigermed Consulting Co Ltd to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 25.3% means that $0.25 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Hangzhou Tigermed Consulting Co Ltd:

  • The MRQ is 25.3%. The company is making a huge profit. +2
  • The TTM is 29.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ25.3%TTM29.5%-4.1%
TTM29.5%YOY37.3%-7.9%
TTM29.5%5Y41.8%-12.3%
5Y41.8%10Y41.8%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ25.3%-5.2%+30.5%
TTM29.5%-6.0%+35.5%
YOY37.3%-1.8%+39.1%
5Y41.8%-8.0%+49.8%
10Y41.8%-4.4%+46.2%
1.1.2. Return on Assets

Shows how efficient Hangzhou Tigermed Consulting Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hangzhou Tigermed Consulting Co Ltd to the Diagnostics & Research industry mean.
  • 1.6% Return on Assets means that Hangzhou Tigermed Consulting Co Ltd generated $0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Hangzhou Tigermed Consulting Co Ltd:

  • The MRQ is 1.6%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.6%TTM2.8%-1.2%
TTM2.8%YOY2.7%+0.1%
TTM2.8%5Y3.1%-0.3%
5Y3.1%10Y3.1%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6%-0.9%+2.5%
TTM2.8%-0.8%+3.6%
YOY2.7%-1.3%+4.0%
5Y3.1%-1.2%+4.3%
10Y3.1%-0.8%+3.9%
1.1.3. Return on Equity

Shows how efficient Hangzhou Tigermed Consulting Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hangzhou Tigermed Consulting Co Ltd to the Diagnostics & Research industry mean.
  • 2.3% Return on Equity means Hangzhou Tigermed Consulting Co Ltd generated $0.02 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Hangzhou Tigermed Consulting Co Ltd:

  • The MRQ is 2.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 4.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.3%TTM4.0%-1.7%
TTM4.0%YOY3.7%+0.4%
TTM4.0%5Y4.6%-0.6%
5Y4.6%10Y4.6%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3%-0.4%+2.7%
TTM4.0%-0.3%+4.3%
YOY3.7%-1.0%+4.7%
5Y4.6%-1.7%+6.3%
10Y4.6%-2.1%+6.7%

1.2. Operating Efficiency of Hangzhou Tigermed Consulting Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Hangzhou Tigermed Consulting Co Ltd is operating .

  • Measures how much profit Hangzhou Tigermed Consulting Co Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hangzhou Tigermed Consulting Co Ltd to the Diagnostics & Research industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Hangzhou Tigermed Consulting Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM5.6%-5.6%
TTM5.6%YOY25.2%-19.6%
TTM5.6%5Y23.9%-18.4%
5Y23.9%10Y23.9%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--9.4%+9.4%
TTM5.6%-0.1%+5.7%
YOY25.2%3.3%+21.9%
5Y23.9%0.3%+23.6%
10Y23.9%-2.7%+26.6%
1.2.2. Operating Ratio

Measures how efficient Hangzhou Tigermed Consulting Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 1.33 means that the operating costs are $1.33 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Hangzhou Tigermed Consulting Co Ltd:

  • The MRQ is 1.330. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.166. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.330TTM1.166+0.164
TTM1.166YOY1.346-0.181
TTM1.1665Y1.259-0.093
5Y1.25910Y1.2590.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3301.307+0.023
TTM1.1661.299-0.133
YOY1.3461.277+0.069
5Y1.2591.246+0.013
10Y1.2591.215+0.044

1.3. Liquidity of Hangzhou Tigermed Consulting Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Hangzhou Tigermed Consulting Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 2.68 means the company has $2.68 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Hangzhou Tigermed Consulting Co Ltd:

  • The MRQ is 2.684. The company is able to pay all its short-term debts. +1
  • The TTM is 2.800. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.684TTM2.800-0.116
TTM2.800YOY3.463-0.663
TTM2.8005Y4.712-1.912
5Y4.71210Y4.7120.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6842.183+0.501
TTM2.8002.341+0.459
YOY3.4632.625+0.838
5Y4.7122.989+1.723
10Y4.7122.958+1.754
1.3.2. Quick Ratio

Measures if Hangzhou Tigermed Consulting Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hangzhou Tigermed Consulting Co Ltd to the Diagnostics & Research industry mean.
  • A Quick Ratio of 0.28 means the company can pay off $0.28 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Hangzhou Tigermed Consulting Co Ltd:

  • The MRQ is 0.281. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.526. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.281TTM1.526-1.245
TTM1.526YOY2.274-0.747
TTM1.5265Y2.495-0.968
5Y2.49510Y2.4950.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2811.310-1.029
TTM1.5261.437+0.089
YOY2.2741.764+0.510
5Y2.4951.952+0.543
10Y2.4952.080+0.415

1.4. Solvency of Hangzhou Tigermed Consulting Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Hangzhou Tigermed Consulting Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hangzhou Tigermed Consulting Co Ltd to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.18 means that Hangzhou Tigermed Consulting Co Ltd assets are financed with 18.4% credit (debt) and the remaining percentage (100% - 18.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Hangzhou Tigermed Consulting Co Ltd:

  • The MRQ is 0.184. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.236. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.184TTM0.236-0.053
TTM0.236YOY0.156+0.080
TTM0.2365Y0.180+0.056
5Y0.18010Y0.1800.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1840.432-0.248
TTM0.2360.431-0.195
YOY0.1560.377-0.221
5Y0.1800.443-0.263
10Y0.1800.446-0.266
1.4.2. Debt to Equity Ratio

Measures if Hangzhou Tigermed Consulting Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hangzhou Tigermed Consulting Co Ltd to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 26.2% means that company has $0.26 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Hangzhou Tigermed Consulting Co Ltd:

  • The MRQ is 0.262. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.335. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.262TTM0.335-0.073
TTM0.335YOY0.213+0.121
TTM0.3355Y0.270+0.065
5Y0.27010Y0.2700.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2620.606-0.344
TTM0.3350.595-0.260
YOY0.2130.603-0.390
5Y0.2700.636-0.366
10Y0.2700.730-0.460

2. Market Valuation of Hangzhou Tigermed Consulting Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Hangzhou Tigermed Consulting Co Ltd generates.

  • Above 15 is considered overpriced but always compare Hangzhou Tigermed Consulting Co Ltd to the Diagnostics & Research industry mean.
  • A PE ratio of 16.86 means the investor is paying $16.86 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Hangzhou Tigermed Consulting Co Ltd:

  • The EOD is 11.919. Based on the earnings, the company is underpriced. +1
  • The MRQ is 16.862. Based on the earnings, the company is fair priced.
  • The TTM is 22.799. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD11.919MRQ16.862-4.944
MRQ16.862TTM22.799-5.936
TTM22.799YOY28.394-5.596
TTM22.7995Y31.511-8.713
5Y31.51110Y31.5110.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD11.919-0.293+12.212
MRQ16.862-0.567+17.429
TTM22.799-0.341+23.140
YOY28.394-0.242+28.636
5Y31.511-0.129+31.640
10Y31.5113.396+28.115
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Hangzhou Tigermed Consulting Co Ltd:

  • The EOD is 24.232. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 34.284. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is -39.392. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD24.232MRQ34.284-10.052
MRQ34.284TTM-39.392+73.676
TTM-39.392YOY-21.051-18.342
TTM-39.3925Y37.349-76.741
5Y37.34910Y37.3490.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD24.232-0.416+24.648
MRQ34.284-0.917+35.201
TTM-39.392-1.986-37.406
YOY-21.051-3.236-17.815
5Y37.349-2.150+39.499
10Y37.349-3.427+40.776
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Hangzhou Tigermed Consulting Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 1.35 means the investor is paying $1.35 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Hangzhou Tigermed Consulting Co Ltd:

  • The EOD is 0.954. Based on the equity, the company is cheap. +2
  • The MRQ is 1.350. Based on the equity, the company is underpriced. +1
  • The TTM is 2.337. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.954MRQ1.350-0.396
MRQ1.350TTM2.337-0.987
TTM2.337YOY3.305-0.968
TTM2.3375Y3.346-1.010
5Y3.34610Y3.3460.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD0.9542.000-1.046
MRQ1.3502.140-0.790
TTM2.3372.120+0.217
YOY3.3053.061+0.244
5Y3.3463.399-0.053
10Y3.3464.128-0.782
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Hangzhou Tigermed Consulting Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--4.8530.731+564%0.804+503%1.791+171%1.791+171%
Book Value Per Share--30.45227.330+11%26.502+15%21.429+42%21.429+42%
Current Ratio--2.6842.800-4%3.463-23%4.712-43%4.712-43%
Debt To Asset Ratio--0.1840.236-22%0.156+18%0.180+2%0.180+2%
Debt To Equity Ratio--0.2620.335-22%0.213+23%0.270-3%0.270-3%
Dividend Per Share--0.6250.174+260%0.148+322%0.131+378%0.131+378%
Eps--0.6090.785-22%0.837-27%0.694-12%0.694-12%
Free Cash Flow Per Share--0.3000.269+12%0.341-12%0.272+10%0.272+10%
Free Cash Flow To Equity Per Share--0.3000.565-47%0.581-48%1.181-75%1.181-75%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--12.980--------
Intrinsic Value_10Y_min--11.209--------
Intrinsic Value_1Y_max--1.213--------
Intrinsic Value_1Y_min--1.192--------
Intrinsic Value_3Y_max--3.712--------
Intrinsic Value_3Y_min--3.543--------
Intrinsic Value_5Y_max--6.291--------
Intrinsic Value_5Y_min--5.834--------
Market Cap3576781250.000-902%35856388842.00054449802155.750-34%76065719861.250-53%71321867494.224-50%71321867494.224-50%
Net Profit Margin--0.2530.295-14%0.373-32%0.418-39%0.418-39%
Operating Margin---0.056-100%0.252-100%0.239-100%0.239-100%
Operating Ratio--1.3301.166+14%1.346-1%1.259+6%1.259+6%
Pb Ratio0.954-41%1.3502.337-42%3.305-59%3.346-60%3.346-60%
Pe Ratio11.919-41%16.86222.799-26%28.394-41%31.511-46%31.511-46%
Price Per Share29.050-41%41.10062.413-34%87.188-53%81.747-50%81.747-50%
Price To Free Cash Flow Ratio24.232-41%34.284-39.392+215%-21.051+161%37.349-8%37.349-8%
Price To Total Gains Ratio5.303-41%7.503-4.670+162%95.034-92%112.252-93%112.252-93%
Quick Ratio--0.2811.526-82%2.274-88%2.495-89%2.495-89%
Return On Assets--0.0160.028-42%0.027-40%0.031-47%0.031-47%
Return On Equity--0.0230.040-42%0.037-36%0.046-49%0.046-49%
Total Gains Per Share--5.4780.905+505%0.952+475%1.922+185%1.922+185%
Usd Book Value--3395248516.0113047159137.541+11%2954950667.489+15%2354005930.228+44%2354005930.228+44%
Usd Book Value Change Per Share--0.6200.093+564%0.103+503%0.229+171%0.229+171%
Usd Book Value Per Share--3.8923.493+11%3.387+15%2.739+42%2.739+42%
Usd Dividend Per Share--0.0800.022+260%0.019+322%0.017+378%0.017+378%
Usd Eps--0.0780.100-22%0.107-27%0.089-12%0.089-12%
Usd Free Cash Flow--33415383.70829951208.917+12%37966368.396-12%26567938.951+26%26567938.951+26%
Usd Free Cash Flow Per Share--0.0380.034+12%0.044-12%0.035+10%0.035+10%
Usd Free Cash Flow To Equity Per Share--0.0380.072-47%0.074-48%0.151-75%0.151-75%
Usd Market Cap457112643.750-902%4582446494.0086958684715.505-34%9721198998.268-53%9114934665.762-50%9114934665.762-50%
Usd Price Per Share3.713-41%5.2537.976-34%11.143-53%10.447-50%10.447-50%
Usd Profit--67938541.276113128059.515-40%93270315.230-27%81269181.861-16%81269181.861-16%
Usd Revenue--268235712.474378447848.087-29%249774767.382+7%213329508.473+26%213329508.473+26%
Usd Total Gains Per Share--0.7000.116+505%0.122+475%0.246+185%0.246+185%
 EOD+4 -4MRQTTM+18 -17YOY+14 -215Y+18 -1710Y+18 -17

3.2. Fundamental Score

Let's check the fundamental score of Hangzhou Tigermed Consulting Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1511.919
Price to Book Ratio (EOD)Between0-10.954
Net Profit Margin (MRQ)Greater than00.253
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.281
Current Ratio (MRQ)Greater than12.684
Debt to Asset Ratio (MRQ)Less than10.184
Debt to Equity Ratio (MRQ)Less than10.262
Return on Equity (MRQ)Greater than0.150.023
Return on Assets (MRQ)Greater than0.050.016
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Hangzhou Tigermed Consulting Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.147
Ma 20Greater thanMa 5028.695
Ma 50Greater thanMa 10027.544
Ma 100Greater thanMa 20033.157
OpenGreater thanClose28.300
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets30,072,449
Total Liabilities5,521,216
Total Stockholder Equity21,059,878
 As reported
Total Liabilities 5,521,216
Total Stockholder Equity+ 21,059,878
Total Assets = 30,072,449

Assets

Total Assets30,072,449
Total Current Assets11,465,405
Long-term Assets18,607,044
Total Current Assets
Cash And Cash Equivalents 7,417,101
Short-term Investments 25,000
Net Receivables 1,176,009
Inventory 27,239
Other Current Assets 34,544
Total Current Assets  (as reported)11,465,405
Total Current Assets  (calculated)8,679,894
+/- 2,785,511
Long-term Assets
Property Plant Equipment 1,432,293
Goodwill 2,833,171
Intangible Assets 313,053
Long-term Assets Other 17,343
Long-term Assets  (as reported)18,607,044
Long-term Assets  (calculated)4,595,860
+/- 14,011,185

Liabilities & Shareholders' Equity

Total Current Liabilities4,272,088
Long-term Liabilities1,249,128
Total Stockholder Equity21,059,878
Total Current Liabilities
Short Long Term Debt 2,533,838
Accounts payable 168,544
Other Current Liabilities 47,523
Total Current Liabilities  (as reported)4,272,088
Total Current Liabilities  (calculated)2,749,905
+/- 1,522,183
Long-term Liabilities
Long term Debt 514,545
Capital Lease Obligations Min Short Term Debt440,138
Long-term Liabilities  (as reported)1,249,128
Long-term Liabilities  (calculated)954,683
+/- 294,445
Total Stockholder Equity
Retained Earnings 8,674,217
Total Stockholder Equity (as reported)21,059,878
Total Stockholder Equity (calculated)8,674,217
+/- 12,385,661
Other
Capital Stock872,418
Common Stock Shares Outstanding 872,418
Net Invested Capital 24,108,261
Net Working Capital 7,193,317
Property Plant and Equipment Gross 1,432,293



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
6,310,006
7,532,651
8,242,151
9,267,418
18,829,544
19,506,058
20,281,478
21,220,911
21,955,208
23,741,172
24,803,252
25,703,180
27,140,007
27,446,510
28,172,128
29,666,675
30,072,449
30,072,44929,666,67528,172,12827,446,51027,140,00725,703,18024,803,25223,741,17221,955,20821,220,91120,281,47819,506,05818,829,5449,267,4188,242,1517,532,6516,310,006
   > Total Current Assets 
3,251,859
3,369,960
3,500,584
3,824,603
12,514,094
11,645,970
11,497,375
11,458,922
10,457,225
10,851,801
10,497,396
10,711,950
11,034,455
11,105,157
11,215,265
11,976,418
11,465,405
11,465,40511,976,41811,215,26511,105,15711,034,45510,711,95010,497,39610,851,80110,457,22511,458,92211,497,37511,645,97012,514,0943,824,6033,500,5843,369,9603,251,859
       Cash And Cash Equivalents 
2,066,735
2,042,306
2,062,159
2,253,095
10,965,557
10,123,891
9,712,470
9,558,961
8,408,147
8,544,356
7,985,048
7,774,935
7,749,593
7,858,140
7,616,131
8,137,911
7,417,101
7,417,1018,137,9117,616,1317,858,1407,749,5937,774,9357,985,0488,544,3568,408,1479,558,9619,712,47010,123,89110,965,5572,253,0952,062,1592,042,3062,066,735
       Short-term Investments 
0
0
99,841
6,000
6,000
26,000
146,600
91,000
49,680
29,180
36,500
35,569
31,000
79,140
32,841
52,688
25,000
25,00052,68832,84179,14031,00035,56936,50029,18049,68091,000146,60026,0006,0006,00099,84100
       Net Receivables 
1,056,733
1,222,009
1,319,569
1,422,189
1,430,030
1,435,170
1,558,218
1,733,199
1,911,519
2,177,383
2,365,164
2,754,884
3,031,968
3,123,389
1,077,375
3,684,667
1,176,009
1,176,0093,684,6671,077,3753,123,3893,031,9682,754,8842,365,1642,177,3831,911,5191,733,1991,558,2181,435,1701,430,0301,422,1891,319,5691,222,0091,056,733
       Inventory 
689
1,206
2,413
1,296
1,553
4,721
5,263
5,525
5,887
6,095
7,642
16,965
35,093
22,204
23,127
26,535
27,239
27,23926,53523,12722,20435,09316,9657,6426,0955,8875,5255,2634,7211,5531,2962,4131,206689
       Other Current Assets 
21,081
34,146
116,444
106,454
110,954
55,187
74,824
68,550
81,992
93,972
103,043
128,878
186,801
77,500
41,584
103,918
34,544
34,544103,91841,58477,500186,801128,878103,04393,97281,99268,55074,82455,187110,954106,454116,44434,14621,081
   > Long-term Assets 
3,058,147
4,162,691
4,741,567
5,442,815
6,315,450
7,860,088
8,784,103
9,761,988
11,497,983
12,889,371
14,305,856
14,991,230
16,105,552
16,339,262
16,956,863
17,690,257
18,607,044
18,607,04417,690,25716,956,86316,339,26216,105,55214,991,23014,305,85612,889,37111,497,9839,761,9888,784,1037,860,0886,315,4505,442,8154,741,5674,162,6913,058,147
       Property Plant Equipment 
0
425,812
565,304
578,296
599,078
682,669
743,400
864,916
1,035,802
1,123,377
1,151,158
1,242,505
1,308,927
1,326,025
1,325,984
1,371,295
1,432,293
1,432,2931,371,2951,325,9841,326,0251,308,9271,242,5051,151,1581,123,3771,035,802864,916743,400682,669599,078578,296565,304425,8120
       Goodwill 
1,100,714
1,157,831
1,363,124
1,354,681
1,525,236
1,444,518
1,445,416
1,463,188
1,887,491
1,778,947
2,220,299
2,347,880
2,502,677
2,485,018
2,495,839
2,549,178
2,833,171
2,833,1712,549,1782,495,8392,485,0182,502,6772,347,8802,220,2991,778,9471,887,4911,463,1881,445,4161,444,5181,525,2361,354,6811,363,1241,157,8311,100,714
       Intangible Assets 
33,411
96,449
93,347
96,412
83,490
141,755
136,489
130,855
121,026
250,635
261,715
289,549
312,543
276,147
335,651
270,413
313,053
313,053270,413335,651276,147312,543289,549261,715250,635121,026130,855136,489141,75583,49096,41293,34796,44933,411
       Long-term Assets Other 
10,489
11,123
8,723
14,323
68,214
110,484
44,387
68,105
17,641
101,605
129,144
66,615
77,056
62,564
49,931
29,351
17,343
17,34329,35149,93162,56477,05666,615129,144101,60517,64168,10544,387110,48468,21414,3238,72311,12310,489
> Total Liabilities 
1,310,867
2,011,003
2,382,065
2,624,077
1,303,337
1,647,584
1,771,231
1,973,942
2,354,551
3,135,974
3,629,856
4,206,272
4,945,848
7,818,065
4,853,583
9,028,180
5,521,216
5,521,2169,028,1804,853,5837,818,0654,945,8484,206,2723,629,8563,135,9742,354,5511,973,9421,771,2311,647,5841,303,3372,624,0772,382,0652,011,0031,310,867
   > Total Current Liabilities 
1,125,069
1,790,692
1,923,941
2,172,501
899,517
1,139,339
1,342,508
1,450,722
1,711,731
2,412,714
2,984,318
3,434,473
4,058,716
3,729,567
3,796,995
4,633,251
4,272,088
4,272,0884,633,2513,796,9953,729,5674,058,7163,434,4732,984,3182,412,7141,711,7311,450,7221,342,5081,139,339899,5172,172,5011,923,9411,790,6921,125,069
       Short Long Term Debt 
451,894
863,772
983,516
1,251,779
0
0
0
0
300,000
492,320
1,062,059
1,760,905
2,100,268
1,848,658
2,082,586
2,363,113
2,533,838
2,533,8382,363,1132,082,5861,848,6582,100,2681,760,9051,062,059492,320300,00000001,251,779983,516863,772451,894
       Accounts payable 
34,191
75,191
62,986
60,388
61,405
101,295
81,784
122,661
126,129
147,867
177,955
162,759
193,029
157,958
175,982
174,397
168,544
168,544174,397175,982157,958193,029162,759177,955147,867126,129122,66181,784101,29561,40560,38862,98675,19134,191
       Other Current Liabilities 
35,435
662,524
777,562
710,060
684,579
803,108
1,190,829
1,110,579
1,109,819
1,347,334
1,593,767
1,153,089
1,500,062
23,730
52,089
1,662,746
47,523
47,5231,662,74652,08923,7301,500,0621,153,0891,593,7671,347,3341,109,8191,110,5791,190,829803,108684,579710,060777,562662,52435,435
   > Long-term Liabilities 
185,798
220,311
458,124
451,576
403,820
508,245
428,724
523,220
642,820
723,260
645,538
771,800
887,132
1,035,913
1,056,588
1,075,576
1,249,128
1,249,1281,075,5761,056,5881,035,913887,132771,800645,538723,260642,820523,220428,724508,245403,820451,576458,124220,311185,798
       Long term Debt Total 
0
0
388,413
391,102
0
279,021
0
323,885
0
406,839
0
445,642
0
733,617
0
741,674
0
0741,6740733,6170445,6420406,8390323,8850279,0210391,102388,41300
       Capital Lease Obligations Min Short Term Debt
89,049
117,750
244,302
243,227
237,156
279,021
283,046
323,885
375,187
406,839
398,326
408,150
506,586
488,976
466,591
453,103
440,138
440,138453,103466,591488,976506,586408,150398,326406,839375,187323,885283,046279,021237,156243,227244,302117,75089,049
       Long-term Liabilities Other 
175,349
154,250
380,402
379,327
0
0
22,283
0
126,883
0
68,896
0
0
0
40,723
0
0
0040,72300068,8960126,883022,28300379,327380,402154,250175,349
       Deferred Long Term Liability 
0
19,814
18,646
18,087
24,535
33,428
32,038
33,307
38,066
35,197
38,435
41,423
165,349
211,038
0
200,509
0
0200,5090211,038165,34941,42338,43535,19738,06633,30732,03833,42824,53518,08718,64619,8140
> Total Stockholder Equity
3,864,272
4,225,458
4,519,765
5,185,695
15,990,361
16,118,568
16,423,147
17,011,686
17,183,367
18,123,626
18,404,968
18,654,562
19,191,150
19,628,445
20,145,013
20,638,495
21,059,878
21,059,87820,638,49520,145,01319,628,44519,191,15018,654,56218,404,96818,123,62617,183,36717,011,68616,423,14716,118,56815,990,3615,185,6954,519,7654,225,4583,864,272
   Common Stock
0
749,508
749,468
749,456
872,580
872,484
872,484
872,467
872,391
872,438
872,438
872,418
872,418
872,418
0
872,418
0
0872,4180872,418872,418872,418872,438872,438872,391872,467872,484872,484872,580749,456749,468749,5080
   Retained Earnings 
1,365,475
1,934,517
2,189,486
2,725,066
3,044,281
3,475,665
3,931,145
4,468,908
4,994,994
6,088,107
6,606,524
6,847,648
7,260,303
7,662,196
7,838,790
8,574,811
8,674,217
8,674,2178,574,8117,838,7907,662,1967,260,3036,847,6486,606,5246,088,1074,994,9944,468,9083,931,1453,475,6653,044,2812,725,0662,189,4861,934,5171,365,475
   Capital Surplus 
0
0
1,043,433
1,050,575
0
11,488,836
0
11,490,687
0
11,495,982
0
11,509,648
0
11,509,648
0
11,509,648
0
011,509,648011,509,648011,509,648011,495,982011,490,687011,488,83601,050,5751,043,43300
   Treasury Stock0000000-579,1860-80,2200-157,9120-160,801-210,03300
   Other Stockholders Equity 
0
26,299
39,656
40,401
-35,794
-92,013
-89,734
-126,131
-113,789
-155,993
-156,538
-13,975
108,969
56,748
0
135,422
0
0135,422056,748108,969-13,975-156,538-155,993-113,789-126,131-89,734-92,013-35,79440,40139,65626,2990



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue7,329,931
Cost of Revenue-4,410,482
Gross Profit2,919,4482,919,448
 
Operating Income (+$)
Gross Profit2,919,448
Operating Expense-5,538,100
Operating Income1,791,831-2,618,652
 
Operating Expense (+$)
Research Development258,907
Selling General Administrative497,061
Selling And Marketing Expenses-
Operating Expense5,538,100755,968
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-124,840
Net Interest Income124,840
 
Pretax Income (+$)
Operating Income1,791,831
Net Interest Income124,840
Other Non-Operating Income Expenses-
Income Before Tax (EBT)2,893,8461,791,831
EBIT - interestExpense = 0
2,281,498
2,281,498
Interest Expense-
Earnings Before Interest and Taxes (EBIT)-2,893,846
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax2,893,846
Tax Provision-366,508
Net Income From Continuing Ops2,527,3382,527,338
Net Income2,281,498
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--124,840
 

Technical Analysis of Hangzhou Tigermed Consulting Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Hangzhou Tigermed Consulting Co Ltd. The general trend of Hangzhou Tigermed Consulting Co Ltd is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Hangzhou Tigermed Consulting Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Hangzhou Tigermed Consulting Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 35.30 < 36.70 < 36.75.

The bearish price targets are: 24.50 > 22.10.

Tweet this
Hangzhou Tigermed Consulting Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Hangzhou Tigermed Consulting Co Ltd. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Hangzhou Tigermed Consulting Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Hangzhou Tigermed Consulting Co Ltd. The current macd is 0.63656228.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Hangzhou Tigermed Consulting Co Ltd price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Hangzhou Tigermed Consulting Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Hangzhou Tigermed Consulting Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Hangzhou Tigermed Consulting Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartHangzhou Tigermed Consulting Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Hangzhou Tigermed Consulting Co Ltd. The current adx is 25.31.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Hangzhou Tigermed Consulting Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Hangzhou Tigermed Consulting Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Hangzhou Tigermed Consulting Co Ltd. The current sar is 26.30.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Hangzhou Tigermed Consulting Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Hangzhou Tigermed Consulting Co Ltd. The current rsi is 51.15. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Hangzhou Tigermed Consulting Co Ltd Daily Relative Strength Index (RSI) ChartHangzhou Tigermed Consulting Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Hangzhou Tigermed Consulting Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hangzhou Tigermed Consulting Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Hangzhou Tigermed Consulting Co Ltd Daily Stochastic Oscillator ChartHangzhou Tigermed Consulting Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Hangzhou Tigermed Consulting Co Ltd. The current cci is -7.50968992.

Hangzhou Tigermed Consulting Co Ltd Daily Commodity Channel Index (CCI) ChartHangzhou Tigermed Consulting Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Hangzhou Tigermed Consulting Co Ltd. The current cmo is -0.5643688.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Hangzhou Tigermed Consulting Co Ltd Daily Chande Momentum Oscillator (CMO) ChartHangzhou Tigermed Consulting Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Hangzhou Tigermed Consulting Co Ltd. The current willr is -58.41121495.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Hangzhou Tigermed Consulting Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Hangzhou Tigermed Consulting Co Ltd Daily Williams %R ChartHangzhou Tigermed Consulting Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Hangzhou Tigermed Consulting Co Ltd.

Hangzhou Tigermed Consulting Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Hangzhou Tigermed Consulting Co Ltd. The current atr is 2.1189098.

Hangzhou Tigermed Consulting Co Ltd Daily Average True Range (ATR) ChartHangzhou Tigermed Consulting Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Hangzhou Tigermed Consulting Co Ltd. The current obv is 13,512,952.

Hangzhou Tigermed Consulting Co Ltd Daily On-Balance Volume (OBV) ChartHangzhou Tigermed Consulting Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Hangzhou Tigermed Consulting Co Ltd. The current mfi is 53.45.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Hangzhou Tigermed Consulting Co Ltd Daily Money Flow Index (MFI) ChartHangzhou Tigermed Consulting Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Hangzhou Tigermed Consulting Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-05MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Hangzhou Tigermed Consulting Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Hangzhou Tigermed Consulting Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.147
Ma 20Greater thanMa 5028.695
Ma 50Greater thanMa 10027.544
Ma 100Greater thanMa 20033.157
OpenGreater thanClose28.300
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Hangzhou Tigermed Consulting Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Hangzhou Tigermed Consulting Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Hangzhou Tigermed Consulting Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Hangzhou Tigermed Consulting Co Ltd

I send you an email if I find something interesting about Hangzhou Tigermed Consulting Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Hangzhou Tigermed Consulting Co Ltd.

Receive notifications about Hangzhou Tigermed Consulting Co Ltd in your mailbox!